• World-Renowned Academic and Industry Leaders to Discuss Advancements in Synthetic, Medicinal & Process Chemistry at Pharmaron’s 6th Annual Symposium

    1st September, 2016

    Beijing, China, September 1, 2016, Pharmaron’s  6th Annual Symposium, scheduled for Saturday, September 24, 2016, offers Pharmaron staff an opportunity to learn and discuss with experts in the field of synthetic, medicinal and process chemistry. Established in 2011, Pharmaron’s Annual Symposium on Synthetic and Medicinal Chemistry offers its scientists and chemists a forum where they […]

    Read More
  • Dr. Jufeng Wang Appointed as Sr. VP and TFM of the Safety Assessment Facility at Pharmaron

    26th August, 2016

    Pharmaron today announced the appointment of Dr. Jufeng Wang, as Senior Vice President and Test Facility Manager (TFM) of its safety assessment facility in Beijing. Dr. Wang brings over 20 years of experience and skills in the drug safety assessment area, not only in science and technologies, also in leading a GLP compliant safety assessment […]

    Read More
  • Pharmaron Joins NCI’s Chemical Biology Consortium to Fight Against Cancer

    14th June, 2016

    Irvine, California, June 14, 2016 – Pharmaron, a fully integrated contract research organization (CRO) offering laboratory and manufacturing services for pharmaceutical and biotech research and development, has joined a national network of scientists on the leading edge of drug discovery and development in the fight against cancer, centered at the Frederick National Laboratory for Cancer […]

    Read More
  • Pharmaron Acquires Quotient Bioresearch

    4th February, 2016

    Pharmaron Acquires Quotient Bioresearch To enhance service offerings and increase presence in global markets BEIJING, February 4, 2016 – Pharmaron, a fully integrated contract research organization (CRO) offering laboratory and manufacturing services for pharmaceutical and biotech research and development, today announced that it acquired Quotient Bioresearch (Quotient). Quotient, a UK-based CRO with more than 200 […]

    Read More
  • Pharmaron Receives a CFDA GLP Certificate for its Safety Assessment Facility

    15th December, 2015

    Pharmaron Receives a CFDA GLP Certificate for its Safety Assessment Facility Beijing, Dec. 15, 2015_Pharmaron announces that the company has received a Certificate of GLP Compliance, covering genetic toxicology and developmental and reproductive toxicology (Segments I and II), from the Chinese Food and Drug Administration (CFDA) for its GLP safety assessment facility in Beijing.  This […]

    Read More